Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01673230
Other study ID # 2012-A00364-39
Secondary ID LOC/12-01
Status Completed
Phase N/A
First received
Last updated
Start date September 2012
Est. completion date December 2015

Study information

Verified date March 2016
Source Rennes University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Low Cardiac Output Syndrome occurs frequently after cardiac surgery, especially when pre-operative LVEF is altered (LVEF≤45%). The correction of hemodynamic failure requires adapted treatments: fluid expansion and/or inotropic or vasoactive drugs. Predictive indices of a response to fluid challenge may allow an earlier hemodynamic optimization, which has not been showed until now when LVEF is altered.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date December 2015
Est. primary completion date December 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- patients >18 years old in the immediate post-operative period after cardiac surgery

- ASA 1 - 3

- Pre-operative LVEF=45%

- Sedated with Ramsay score: 6

- Mechanically ventilated with tidal volume at 8ml/kg, PEEP at 0mmHg, I/Eat 0,5

- With hemodynamic failure: SAP=90mmHg and/or inotropic or vasoactive drug started in the operating room and/or clinical sign of shock and/or CI =2,3l/min/m2

- Affiliation to Health Insurance

- Consent form signed

Exclusion Criteria:

- Cardiac arrhythmia: frequent atrial or ventricular extra systoles, atrial fibrillation

- Intracardiac shunt

- Weight less than 50 kg

- History of central nervous system illness

- Pulmonary oedema (clinical and/or radiological and/or wedge pressure>18mmHg)

- Right ventricular failure suspected (CVP> wedge pressure) or diagnosed (trans thoracic and/or transesophageal echocardiography)

- Acute kidney injury with oligoanuria

- Severe post operative bleeding (chest tubes volume of >200ml/h for 3 hours or more)

- Severe hypoxia (PaO2/FIO2< 100)

- Administrative control (patient under guardianship or curatorship)

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
cardiac surgery for ventricular dysfunction
For each included patient during the immediate post operative period, hemodynamic variables will be recorded (continuous arterial pressure, ECG, photoplethysmographic curve, CVP, wedge pressure, respiratory pressure), at rest (proclive 45°), during fluid expansion (physiological saline).

Locations

Country Name City State
France Rennes University Hospital Rennes Brittany

Sponsors (1)

Lead Sponsor Collaborator
Rennes University Hospital

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Measure of ?PP, ?POP, PVI and Cardiac index (CI) To assess the sensibility and specificity of ?PP, ?POP, PVI, after fluid expansion in case of hemodynamic failure in the immediate post-operative period after cardiac surgery, when pre-operative LVEF is altered. 2 hours
Secondary Measure of Systolic, diastolic and mean arterial pressure (SAP, DAP, MAP), Central venous pressure (CVP) and wedge pressure. Secondary objectives :
Early optimization of hemodynamics after cardiac surgery,
To determine optimal threshold for ?PP, ?POP and PVI,
To compare dynamic (?PP, ?POP and PVI) with static (central venous pressure: CVP, wedge pressure) indices
2 hours
See also
  Status Clinical Trial Phase
Completed NCT03799133 - Safety and Efficacy of the Gastric Reactance (XL) in Patients Post-operated of Elective Cardiac Surgery N/A
Not yet recruiting NCT02784912 - Biomarkers in Risk Stratification of Sustainted Ventricular Tachycardia or Electrical Storm After Ablation N/A
Completed NCT00982397 - Safety and Clinical Performance of the Protecta ICD and CRT-D N/A
Completed NCT00187252 - Mascot Study: Management of Atrial Fibrillation (AF) Suppression in AF-Heart Failure (HF) COmorbidity Therapy N/A
Recruiting NCT04848844 - The PAtients pResenTing With COngenital HeaRt DIseAse Register (ARTORIA-R)
Recruiting NCT05851053 - Breast Cancer Long-term Outcomes on Cardiac Functioning: a Longitudinal Study
Recruiting NCT02644850 - Comparison of Gated Blood-pool SPECT and Echocardiogram for Ventricular Function N/A
Completed NCT00526162 - ConsultaTM CRT-D Clinical Evaluation Study N/A
Terminated NCT00524862 - Standard Drug Therapy vs. Implanted Defibrillator for Primary Prevention of Sudden Cardiac Death N/A
Withdrawn NCT00166010 - Effects of Nesiritide in Pediatric Patients With Heart Failure N/A
Completed NCT00370643 - Glucose Control in Open Heart Surgery Phase 1
Not yet recruiting NCT04068116 - Impact of Ischemic Post-conditioning N/A
Enrolling by invitation NCT03701997 - Registry to Monitor Berlin Heart EXCOR® Pediatric VAD as a Bridge to Cardiac Transplantation.
Completed NCT02497950 - HeartMate 3 ELEVATE™ Registry
Recruiting NCT05934071 - Effects of the Sodium-glucose Cotransporter 2 Inhibitors+Sacubitril/Valsartan Therapy in Patients With HFrEF.
Recruiting NCT02816047 - Austrian Wearable Cardioverter Defibrillator Registry
Completed NCT04634708 - The Use of the EXCOR Active Driving Unit for Mobilization of Pediatric Patients With Ventricular Assist Device Support
Terminated NCT02820441 - Benefit of One Month Zopiclone Intake on Adaptative Servoventilation Compliance Phase 4
Completed NCT00893360 - CArdiosphere-Derived aUtologous Stem CElls to Reverse ventricUlar dySfunction Phase 1
Completed NCT01452165 - Peripheral Artery Disease in Vastmanland